BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Skillman B, Kerrigan S. Identification of Suvorexant in Blood Using LC–MS-MS: Important Considerations for Matrix Effects and Quantitative Interferences in Targeted Assays. Journal of Analytical Toxicology 2020;44:245-55. [DOI: 10.1093/jat/bkz083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Skillman B, Kerrigan S. CYP450-Mediated metabolism of suvorexant and investigation of metabolites in forensic case specimens. Forensic Sci Int 2020;312:110307. [PMID: 32473525 DOI: 10.1016/j.forsciint.2020.110307] [Reference Citation Analysis]
2 Skillman B, Kerrigan S. Drug-mediated ion suppression and mitigation of interferences using liquid chromatography-quadrupole/time of flight mass spectrometry (LC-Q/TOF-MS) and liquid chromatography tandem mass spectrometry (LC-MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci 2020;1152:122265. [PMID: 32721861 DOI: 10.1016/j.jchromb.2020.122265] [Reference Citation Analysis]
3 Garcia L, Tiscione NB, Yeatman DT, Richards-Waugh L. Novel and Nonroutine Benzodiazepines and Suvorexant by LC-MS-MS. J Anal Toxicol 2021;45:462-74. [PMID: 33988239 DOI: 10.1093/jat/bkaa109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]